We are live on
!
Find out more
BHCM
Boulder Hill Capital Management Portfolio holdings
AUM
$47.9M
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$108M
Cap. Flow
% of AUM
104.68%
Top 10 Holdings %
Top 10 Hldgs %
32.19%
Holding
151
New
151
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.07M |
| 2 |
Macy's
M
|
+$5.57M |
| 3 |
Kinder Morgan
KMI
|
+$3.94M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$3.69M |
| 5 |
Ambarella
AMBA
|
+$3.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.73% |
| 2 | Healthcare | 18.15% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Energy | 8.63% |
| 5 | Industrials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
26
Core Natural Resources Inc
CNR
$4.45B
| $741K | 0.72% |
+32,600
| New | +$845K |
|
27
Genius Sports
GENI
$2.11B
| $707K | 0.68% |
+93,091
| New | +$1.25M |
|
28
Sprout Social
SPT
$621M
| $707K | 0.68% |
+7,800
| New | +$884K |
|
29
Prothena Corp
PRTA
$450M
| $706K | 0.68% |
+14,300
| New | +$793K |
|
30
Astrana Health
ASTH
$1.77B
| $669K | 0.65% |
+9,100
| New | +$748K |
|
31
Celldex Therapeutics
CLDX
$3.28B
| $653K | 0.63% |
+16,900
| New | +$736K |
|
32
NeoGenomics
NEO
$2.13B
| $652K | 0.63% |
+19,100
| New | +$748K |
|
33
SPS Commerce
SPSC
$2.64B
| $641K | 0.62% |
+4,500
| New | +$674K |
|
34
Cushman & Wakefield Ltd
CWK
$3.25B
| $629K | 0.61% |
+28,300
| New | +$547K |
|
35
Coty
COTY
$2.48B
| $620K | 0.6% |
+59,000
| New | +$554K |
|
36
Bio-Rad Laboratories Class A
BIO
$9.42B
| $604K | 0.58% |
+800
| New | +$599K |
|
37
Surgery Partners
SGRY
$2.03B
| $604K | 0.58% |
+11,300
| New | +$524K |
|
38
Warrior Met Coal
HCC
$4.86B
| $599K | 0.58% |
+23,300
| New | +$560K |
|
39
Dick's Sporting Goods
DKS
$18.7B
| $598K | 0.58% |
+5,200
| New | +$623K |
|
40
Generac Holdings
GNRC
$12.5B
| $598K | 0.58% |
+1,700
| New | +$705K |
|
41
ACI Worldwide
ACIW
$5.42B
| $597K | 0.58% |
+17,200
| New | +$552K |
|
42
Waters Corp
WAT
$39.9B
| $596K | 0.58% |
+1,600
| New | +$560K |
|
43
Dave & Buster's
PLAY
$357M
| $591K | 0.57% |
+15,400
| New | +$571K |
|
44
Alcoa
AA
$13.2B
| $590K | 0.57% |
+9,900
| New | +$496K |
|
|
GTLS
45
DELISTED
Chart Industries
GTLS
| $590K | 0.57% |
+3,700
| New | +$654K |
|
46
Ovintiv
OVV
$16.4B
| $590K | 0.57% |
+17,500
| New | +$625K |
|
47
Paylocity
PCTY
$7.98B
| $590K | 0.57% |
+2,500
| New | +$663K |
|
48
RH
RH
$3.71B
| $590K | 0.57% |
+1,100
| New | +$677K |
|
49
Celsius Holdings
CELH
$7.03B
| $589K | 0.57% |
+23,700
| New | +$656K |
|
50
Yeti Holdings
YETI
$3.95B
| $588K | 0.57% |
+7,100
| New | +$652K |
|
Similar funds
MG
VMV
BHH
LAMC
MAM
BCM
CLCM
LOF
Boulder Hill Capital Management's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Boulder Hill Capital Management, which disclosed 151 positions worth $103M. Its ten largest holdings account for 32% of the portfolio.
Its largest position is iShares Biotechnology ETF: 52,100 shares worth $7.95M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, followed by Healthcare and Consumer Discretionary.
- Boulder Hill Capital Management's largest Q4 2021 buy was iShares Biotechnology ETF: 52,100 shares worth $7.95M.
- Boulder Hill Capital Management's ten largest holdings make up 32% of its $103M portfolio in Q4 2021.
- Boulder Hill Capital Management disclosed 151 positions in Q4 2021, its first 13F filing on record.
Based on Boulder Hill Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.